Trial intelligence / Profile preview

Andrographis paniculata extract for pruritus in chronic liver disease

TCTR20250206011Phase 2Completed

Sponsor
Chiang Rai Prachanukroh Hospital
Start
Jan 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial in chronic liver disease (CLD) comparing Andrographis paniculata extract with Placebo (2 arms). Started Jan 2021; status: completed.

02

Drugs

andrographis paniculata extract
03

Conditions

chronic liver disease (CLD)

Beyond the preview

Go deeper on TCTR20250206011.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250206011.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call